NCT04183387View on ClinicalTrials.gov

Simvastatin in Uveitis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Uveitis
Interventions
DRUG

Simvastatin 40mg

Trial Locations (1)

630047

Laboratory of Clinical Immunopharmacology, Novosibirsk

All Listed Sponsors
lead

Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

OTHER

NCT04183387 - Simvastatin in Uveitis | Biotech Hunter | Biotech Hunter